A detailed history of Oxford Wealth Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Oxford Wealth Group, LLC holds 12,483 shares of NVO stock, worth $1.36 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
12,483
Previous 15,669 20.33%
Holding current value
$1.36 Million
Previous $2.24 Billion 33.55%
% of portfolio
1.21%
Previous 1.54%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $379,357 - $463,308
-3,186 Reduced 20.33%
12,483 $1.49 Billion
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $424,453 - $508,161
3,459 Added 28.33%
15,669 $2.24 Billion
Q1 2024

May 16, 2024

BUY
$102.11 - $135.92 $1.25 Million - $1.66 Million
12,210 New
12,210 $1.57 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Oxford Wealth Group, LLC Portfolio

Follow Oxford Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Wealth Group, LLC with notifications on news.